NATIONAL RESEARCH CORP (NRC) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:NRC • US6373722023

17.62 USD
-4.28 (-19.54%)
Last: Feb 3, 2026, 08:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to NRC. NRC was compared to 102 industry peers in the Health Care Providers & Services industry. NRC scores excellent on profitability, but there are concerns on its financial health. NRC is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year NRC was profitable.
  • NRC had a positive operating cash flow in the past year.
  • NRC had positive earnings in each of the past 5 years.
  • NRC had a positive operating cash flow in each of the past 5 years.
NRC Yearly Net Income VS EBIT VS OCF VS FCFNRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 12.03%, NRC belongs to the top of the industry, outperforming 96.08% of the companies in the same industry.
  • NRC's Return On Equity of 116.86% is amongst the best of the industry. NRC outperforms 99.02% of its industry peers.
  • NRC has a Return On Invested Capital of 21.81%. This is amongst the best in the industry. NRC outperforms 97.06% of its industry peers.
  • NRC had an Average Return On Invested Capital over the past 3 years of 37.14%. This is significantly above the industry average of 9.16%.
  • The 3 year average ROIC (37.14%) for NRC is well above the current ROIC(21.81%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 12.03%
ROE 116.86%
ROIC 21.81%
ROA(3y)22.86%
ROA(5y)24.04%
ROE(3y)62.69%
ROE(5y)57.96%
ROIC(3y)37.14%
ROIC(5y)35.28%
NRC Yearly ROA, ROE, ROICNRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 50 100 150

1.3 Margins

  • NRC has a Profit Margin of 11.76%. This is amongst the best in the industry. NRC outperforms 97.06% of its industry peers.
  • NRC's Profit Margin has declined in the last couple of years.
  • NRC has a better Operating Margin (19.81%) than 97.06% of its industry peers.
  • NRC's Operating Margin has declined in the last couple of years.
  • With an excellent Gross Margin value of 62.05%, NRC belongs to the best of the industry, outperforming 82.35% of the companies in the same industry.
  • NRC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.81%
PM (TTM) 11.76%
GM 62.05%
OM growth 3Y-10.34%
OM growth 5Y-6.05%
PM growth 3Y-11.57%
PM growth 5Y-7.08%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
NRC Yearly Profit, Operating, Gross MarginsNRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

  • NRC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for NRC has been reduced compared to 1 year ago.
  • NRC has less shares outstanding than it did 5 years ago.
  • NRC has a worse debt/assets ratio than last year.
NRC Yearly Shares OutstandingNRC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NRC Yearly Total Debt VS Total AssetsNRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • NRC has an Altman-Z score of 3.35. This indicates that NRC is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.35, NRC is doing good in the industry, outperforming 71.57% of the companies in the same industry.
  • NRC has a debt to FCF ratio of 6.45. This is a slightly negative value and a sign of low solvency as NRC would need 6.45 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 6.45, NRC perfoms like the industry average, outperforming 59.80% of the companies in the same industry.
  • NRC has a Debt/Equity ratio of 5.43. This is a high value indicating a heavy dependency on external financing.
  • NRC's Debt to Equity ratio of 5.43 is on the low side compared to the rest of the industry. NRC is outperformed by 78.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.43
Debt/FCF 6.45
Altman-Z 3.35
ROIC/WACC2.49
WACC8.75%
NRC Yearly LT Debt VS Equity VS FCFNRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 0.51 indicates that NRC may have some problems paying its short term obligations.
  • NRC's Current ratio of 0.51 is on the low side compared to the rest of the industry. NRC is outperformed by 85.29% of its industry peers.
  • NRC has a Quick Ratio of 0.51. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NRC's Quick ratio of 0.51 is on the low side compared to the rest of the industry. NRC is outperformed by 84.31% of its industry peers.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.51
NRC Yearly Current Assets VS Current LiabilitesNRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

  • NRC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.57%.
  • Measured over the past 5 years, NRC shows a small growth in Earnings Per Share. The EPS has been growing by 3.16% on average per year.
  • The Revenue has decreased by -1.99% in the past year.
  • NRC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.42% yearly.
EPS 1Y (TTM)-1.57%
EPS 3Y-4.83%
EPS 5Y3.16%
EPS Q2Q%N/A
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-4.65%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NRC Yearly Revenue VS EstimatesNRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NRC Yearly EPS VS EstimatesNRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2023 0.2 0.4 0.6 0.8 1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 14.10, the valuation of NRC can be described as correct.
  • Compared to the rest of the industry, the Price/Earnings ratio of NRC indicates a rather cheap valuation: NRC is cheaper than 82.35% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of NRC to the average of the S&P500 Index (28.18), we can say NRC is valued slightly cheaper.
Industry RankSector Rank
PE 14.1
Fwd PE N/A
NRC Price Earnings VS Forward Price EarningsNRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NRC is valued a bit cheaper than the industry average as 62.75% of the companies are valued more expensively.
  • NRC's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 32.17
EV/EBITDA 13.81
NRC Per share dataNRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • The excellent profitability rating of NRC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.46
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.92%, NRC has a reasonable but not impressive dividend return.
  • NRC's Dividend Yield is rather good when compared to the industry average which is at 0.47. NRC pays more dividend than 96.08% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, NRC pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.92%

5.2 History

  • The dividend of NRC decreases each year by -17.96%.
  • NRC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-17.96%
Div Incr Years0
Div Non Decr Years0
NRC Yearly Dividends per shareNRC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

  • NRC pays out 65.04% of its income as dividend. This is not a sustainable payout ratio.
DP65.04%
EPS Next 2YN/A
EPS Next 3YN/A
NRC Yearly Income VS Free CF VS DividendNRC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NRC Dividend Payout.NRC Dividend Payout, showing the Payout Ratio.NRC Dividend Payout.PayoutRetained Earnings

More info and screens

NATIONAL RESEARCH CORP

NASDAQ:NRC (2/3/2026, 8:00:02 PM)

17.62

-4.28 (-19.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-03
Earnings (Next)04-27
Inst Owners49.6%
Inst Owner Change-1.95%
Ins Owners10.45%
Ins Owner Change2.71%
Market Cap399.27M
Revenue(TTM)148.58M
Net Income(TTM)16.36M
Analysts45
Price TargetN/A
Short Float %3.27%
Short Ratio4.7
Dividend
Industry RankSector Rank
Dividend Yield 2.92%
Yearly Dividend0.47
Dividend Growth(5Y)-17.96%
DP65.04%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.1
Fwd PE N/A
P/S 2.87
P/FCF 32.17
P/OCF 15.36
P/B 26.62
P/tB N/A
EV/EBITDA 13.81
EPS(TTM)1.25
EY7.09%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.55
FCFY3.11%
OCF(TTM)1.15
OCFY6.51%
SpS6.14
BVpS0.66
TBVpS-2.35
PEG (NY)N/A
PEG (5Y)4.46
Graham Number4.31
Profitability
Industry RankSector Rank
ROA 12.03%
ROE 116.86%
ROCE 28.4%
ROIC 21.81%
ROICexc 22.32%
ROICexgc 79.94%
OM 19.81%
PM (TTM) 11.76%
GM 62.05%
FCFM 8.92%
ROA(3y)22.86%
ROA(5y)24.04%
ROE(3y)62.69%
ROE(5y)57.96%
ROIC(3y)37.14%
ROIC(5y)35.28%
ROICexc(3y)44.1%
ROICexc(5y)48.5%
ROICexgc(3y)275.8%
ROICexgc(5y)N/A
ROCE(3y)48.38%
ROCE(5y)45.95%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-22.2%
ROICexc growth 5Y-12.25%
OM growth 3Y-10.34%
OM growth 5Y-6.05%
PM growth 3Y-11.57%
PM growth 5Y-7.08%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 5.43
Debt/FCF 6.45
Debt/EBITDA 2.2
Cap/Depr 194.42%
Cap/Sales 9.77%
Interest Coverage 7.14
Cash Conversion 75.28%
Profit Quality 75.86%
Current Ratio 0.51
Quick Ratio 0.51
Altman-Z 3.35
F-Score6
WACC8.75%
ROIC/WACC2.49
Cap/Depr(3y)235.57%
Cap/Depr(5y)169.24%
Cap/Sales(3y)9.25%
Cap/Sales(5y)6.89%
Profit Quality(3y)78.03%
Profit Quality(5y)88.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.57%
EPS 3Y-4.83%
EPS 5Y3.16%
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y3.68%
Revenue growth 5Y4.42%
Sales Q2Q%-4.65%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.07%
EBIT growth 3Y-11.35%
EBIT growth 5Y-3.93%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-39.58%
FCF growth 3Y-21.17%
FCF growth 5Y-11.22%
OCF growth 1Y-24.68%
OCF growth 3Y-8.93%
OCF growth 5Y-3.08%

NATIONAL RESEARCH CORP / NRC FAQ

What is the ChartMill fundamental rating of NATIONAL RESEARCH CORP (NRC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to NRC.


Can you provide the valuation status for NATIONAL RESEARCH CORP?

ChartMill assigns a valuation rating of 2 / 10 to NATIONAL RESEARCH CORP (NRC). This can be considered as Overvalued.


What is the profitability of NRC stock?

NATIONAL RESEARCH CORP (NRC) has a profitability rating of 8 / 10.


What are the PE and PB ratios of NATIONAL RESEARCH CORP (NRC) stock?

The Price/Earnings (PE) ratio for NATIONAL RESEARCH CORP (NRC) is 14.1 and the Price/Book (PB) ratio is 26.62.


Can you provide the financial health for NRC stock?

The financial health rating of NATIONAL RESEARCH CORP (NRC) is 3 / 10.